İrfan Çiçin

Researcher Next ID · RN-010004

Researcher · Medicine

, Turkey

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Colorectal Cancer Treatments and Studies

Breast Cancer Treatment Studies

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
The Lancet · 2021 · 10.1016/s0140-6736(21)00228-2
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Journal of Clinical Oncology · 2020 · 10.1200/jco.20.02514
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30539-8
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.06.015
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
New England Journal of Medicine · 2018 · 10.1056/nejmoa1717002

No projects listed.